Zimmer Biomet Holdings, Inc. (SWX:ZBH)
Switzerland · Delayed Price · Currency is CHF | Market Cap | 16.73B |
| Revenue (ttm) | 6.23B |
| Net Income (ttm) | 654.91M |
| Shares Out | n/a |
| EPS (ttm) | 3.27 |
| PE Ratio | 25.55 |
| Forward PE | 12.54 |
| Dividend | 0.82 (1.14%) |
| Ex-Dividend Date | Jun 26, 2025 |
| Volume | n/a |
| Average Volume | 0 |
| Open | n/a |
| Previous Close | 72.00 |
| Day's Range | n/a |
| 52-Week Range | 72.00 - 119.00 |
| Beta | 1.01 |
| RSI | 0.00 |
| Earnings Date | Nov 7, 2025 |
About Zimmer Biomet Holdings
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear... [Read more]
Financial Performance
In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.
Financial numbers in USD Financial StatementsNews
Zimmer Biomet Holdings (ZBH) Issues New Swiss Franc-Denominated Bonds
Zimmer Biomet Holdings (ZBH) Issues New Swiss Franc-Denominated Bonds
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle ...
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference | ZBH Stock News
Zimmer Biomet to Showcase Foot and Ankle Portfolio at the American Orthopedic Foot and Ankle Society Annual Conference
WARSAW, Ind., Sept. 4, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced its participation in the American Orthopedic Foot and ...
Zimmer Biomet Announces New Chief Medical Advisors to Help Improve Standard of Musculoskeletal Care
Dr. Jonathan M. Vigdorchik Named Chief Medical Technology Advisor, Adult Reconstruction and Hip Implants Dr. Anand M.
Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2025
WARSAW, Ind. , Aug. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment ...
Zimmer Biomet to Present at the Annual Morgan Stanley Healthcare Conference
WARSAW, Ind. , Aug. 25, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Annual Morgan ...
Looking Into Zimmer Biomet Holdings's Recent Short Interest
Zimmer Biomet Holdings's (NYSE: ZBH) short percent of float has fallen 19.29% since its last report. The company recently reported that it has 5.93 million shares sold short , which is 3.43% of all r...
4 Stocks to Buy From a Top-Performing Fund Manager
Bill Nygren's Oakmark Fund recently took new positions in these undervalued stocks.
Zimmer Biomet Holdings, Inc. (ZBH) Q2 2025 Earnings Call Transcript
Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook
Zimmer Biomet Holdings, Inc. (NYSE: ZBH) reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99 . The orthopedic implant maker repor...
Zimmer Biomet's $2.08 Billion Q2 Sales Ignite Orthopedic Surge, Boosts Guidance Outlook
Zimmer Biomet Holdings, Inc. ZBH reported second-quarter adjusted earnings of $2.07 per share, up 3% year over year, beating the Street estimates of $1.99.
Zimmer Biomet (ZBH) Q2 Revenue Jumps 7%
Zimmer Biomet raises annual profit forecast on strong demand for medical devices
Zimmer Biomet Holdings raised its full-year adjusted profit forecast and beat second-quarter earnings expectations on Thursday, bolstered by accelerating demand for its hip and knee implants.
Zimmer Biomet Non-GAAP EPS of $2.07 beats by $0.09, revenue of $2.08B beats by $20M
Zimmer Biomet Q2 2025 Earnings Preview
Advanced Wound Care Market to Hit $19.32 Billion by 2030 – What's Fueling the Surge? | MarketsandMarkets™.
Delray Beach, FL, July 30, 2025 (GLOBE NEWSWIRE) -- The global Advanced Wound Care Market , valued at US$12.48 billion in 2024 stood at US$13.37 billion in 2025 and is projected to advance at a resili...
What Does the Market Think About Zimmer Biomet Holdings?
Zimmer Biomet Holdings's (NYSE: ZBH) short percent of float has fallen 13.09% since its last report. The company recently reported that it has 7.34 million shares sold short , which is 4.25% of all r...
P/E Ratio Insights for Zimmer Biomet Holdings
Looking into the current session, Zimmer Biomet Holdings Inc. (NYSE: ZBH) shares are trading at $97.99, after a 1.52% increase. Moreover, over the past month, the stock increased by 5.16% , but in th...
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA
MONOGRAM TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Monogram Technologies Inc. - MGRM
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of ...
Zimmer upgraded to Buy at Roth Capital on Monogram deal
There's short-term uncertainty around stock, technology will help, says Zimmer Biomet CEO Tornos
Zimmer Biomet Chairman, President, and CEO Ivan Tornos joins 'Mad Money' host Jim Cramer to talk recent acquisitions, new tech in development, and more.
Zimmer Biomet To Lead Orthopedic Robotics With Monogram's AI Tech
Zimmer Biomet plans to acquire Monogram and integrate ... Full story available on Benzinga.com
Zimmer Biomet to buy Monogram for $177M in cash
Final Trades: Uber, Delta, Zimmer Holdings and Boeing
The Investment Committee give you their top stocks to watch for the second half.